CLOs on the Move

CooperCompanies

www.coopercos.com

 
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women`s health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.coopercos.com
  • 6101 Bollinger Canyon Road Suite 500
    San Ramon, CA USA 94583
  • Phone: 925.460.3600

Executives

Name Title Contact Details
Nicholas Khadder
General Counsel and Corporate Secretary Profile

Similar Companies

StimGuard

StimGuard is a privately held medical device company engaged in the development, manufacture, and pre-commercialization of wirelessly powered, microtechnology neurostimulators, providing patients with a convenient, safe, minimally invasive, and highly cost-effective urological solution that is easily incorporated into their daily lives. StimGuard`s goal is to evolve its patented, cutting-edge platform into the default for neuromodulation, increasing the accessibility for patients worldwide while lowering the economic impact of urology care management.

Medicus Health

Medicus Health is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cierra

Cierra is a Redwood City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

JenaValve

JenaValve Technology, Inc., based in Irvine, California and Munich, Germany develops, manufactures and markets transcatheter aortic valve implantation (TAVI) systems to treat patients suffering from aortic valve disease. The Company’s transapical TAVI system is CE marked and currently marketed in Europe and other markets worldwide and its new transfemoral TAVI system is currently undergoing clinical evaluation in Europe with a view toward achieving CE Mark in 2015. JenaValve is backed by world-class U.S., European and Asian investors, including Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.

EBT Medical

EBT Medical was founded in 2014 with a mission to develop novel neuromodulation technologies which restore control, dignity and independence to those silently suffering from pelvic floor disorders.